Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2016 April;64(2) > Minerva Cardioangiologica 2016 April;64(2):157-64

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

REVIEWS  THE PREDICTIVE VALUE OF PLASMA BIOMARKERS IN DISCHARGED HEART FAILURE PATIENTS


Minerva Cardioangiologica 2016 April;64(2):157-64

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP

Laura LETO 1, Marzia TESTA 2, Mauro FEOLA 1

1 Cardiovascular Rehabilitation-Heart Failure Unit, Ospedale SS Trinità, Fossano, Cuneo, Italy; 2 School of Geriatry, Università degli Studi di Torino, Turin, Italy


PDF  


BACKGROUND: Natriuretic peptides (NPs) have demonstrated their value to support clinical diagnosis of heart failure (HF); furthermore they are also studied for their prognostic role using them to guide appropriate management strategies. The present review gathers available evidence on prognostic role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients hospitalized for acute decompensated heart failure (ADHF).
METHODS: We searched Medline for English-language studies with the sequent key-words: “acute heart failure/acute decompensated heart failure”, “NT-proBNP/N-terminal pro-B type natriuretic peptide” and “prognosis/mortality/readmission”.
RESULTS: Almost 30 studies were included. NT-proBNP plasma levels at admission are strongly associated with all-cause short-term mortality (2-3 months), mid-term (6-11 months) or long- term mortality (more than one year) of follow-up. Regarding the prognostic power on cardiac death fewer data are available with uncertain results. NT-proBNP at discharge demonstrated its prognostic role for all-cause mortality at mid and long-term follow-up. The relation between NT-proBNP at discharge and cardiovascular mortality or composite end-point is under investigation. A decrease in NT-proBNP values during hospitalization provided prognostic prospects mainly for cardiovascular mortality and HF readmission. A 30% variation in NT-proBNP levels during in-hospital stay seemed to be an optimal cut-off for prognostic role.
CONCLUSIONS: NT-proBNP plasma levels proved to have a strong correlation with all-cause mortality, cardiovascular mortality, morbidity and composite outcomes in patients discharged after an ADHF. A better definition of the correct time of serial measurements and the cut-off values might be the challenge for the future investigations.

top of page

Publication History

Cite this article as

Leto L, Testa M, Feola M. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP. Minerva Cardioangiol 2016 April;64(2):157-64. 

Corresponding author e-mail

m_feola@virgilio.it